Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Finasteride-loaded nanoparticles may help treat alopecia.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Losing eyelashes or eyebrows can be a sign of many different health problems and needs a careful approach to treat effectively.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Chemotherapy causes permanent hair follicle damage by triggering stem cell loss.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Hair casts and cutaneous spicules can be signs of multiple myeloma.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Some cancer treatments can cause permanent hair loss.

International medical graduates outperformed U.S. graduates on an internal medicine exam.

International medical graduates outperformed U.S. graduates on an internal medicine exam.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Itraconazole may cause low platelet and white blood cell counts.